To overcome the resistance to chemotherapy by targeting IL-6, tocilizumab (anti-IL-6 receptor monoclonal antibody) was used in treatment and it effectively enhanced the anti-tumor effect of chemotherapy in gastric cancer [89]. This evidence concerns the gene IL6 and neoplasm.